Advertisement

Reactions Weekly

, Volume 1744, Issue 1, pp 155–155 | Cite as

Infliximab

Dyspnoea and asthenia: 2 case reports
Case report
  • 13 Downloads

Reference

  1. Fabiani C, et al. Long-term retention rates of adalimumab and infliximab in non-infectious intermediate, posterior, and panuveitis. Clinical Rheumatology 38: 63-70, No. 1, 18 Jan 2019. Available from: URL: http://doi.org/10.1007/s10067-018-4069-3 - Italy

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations